Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.
Mol Diagn Ther. 2010 Oct 1;14(5):283-93. doi: 10.1007/BF03256384.
Outbreaks of viral respiratory disease in institutions may be associated with high morbidity and mortality, depending upon the viral etiology and the age and immune status of the affected patients. Control of outbreaks may include isolation and/or cohorting, and prophylaxis or treatment with specific antiviral agents may be indicated, all dependent upon the specific cause of the outbreak. Conventional methods of viral diagnosis detect only a limited number of the viruses that are known to cause outbreaks. The availability of sensitive and specific molecular assays has facilitated rapid diagnosis of a wider range of viruses from respiratory outbreaks. Molecular methods have distinct advantages over conventional methods, including the ability to rapidly develop assays for emerging viruses and new variants of existing viruses. In addition, molecular testing allows rapid detection of resistance to antiviral agents or mutations leading to increased virulence. However, high-throughput molecular testing requires batch processes that may compromise the ability to respond quickly to urgent testing demands.
医疗机构中病毒性呼吸道疾病的爆发可能与高发病率和死亡率有关,具体取决于病毒病因以及受影响患者的年龄和免疫状态。爆发的控制可能包括隔离和/或分组,并且可能需要使用特定的抗病毒药物进行预防或治疗,所有这些都取决于爆发的具体原因。传统的病毒诊断方法只能检测到已知引起爆发的有限数量的病毒。敏感和特异的分子检测方法的出现促进了对呼吸道爆发中更广泛的病毒的快速诊断。分子方法与传统方法有明显的优势,包括能够快速为新兴病毒和现有病毒的新变体开发检测方法。此外,分子检测可以快速检测到对抗病毒药物的耐药性或导致毒力增加的突变。然而,高通量分子检测需要批量处理,这可能会影响快速响应紧急检测需求的能力。